Gad Soffer, Chief Operating Officer at Atara Biotherapeutics, Inc. (ATRA), sold 1,480 shares at $18.41 ($27K) on 2016-11-17, disclosed to the SEC on 2016-11-22.
Scheduled sale ($27k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ATRA | SELL | 2017-08-17 | $141K | — | Filing → |
| ATRA | SELL | 2017-05-17 | $192K | — | Filing → |
| ATRA | SELL | 2017-03-13 | $50K | — | Filing → |